Anderson JJ, Wallin KJ, Spencer L: Split thickness skin grafts for the treatment of non-healing foot and leg ulcers in patients with diabetes: a retrospective review. Diabet Foot Ankle[Published online ahead of print February 20,2012; doi:].
Anderson JJ, Wallin KJ, Spencer L: Split thickness skin grafts for the treatment of non-healing foot and leg ulcers in patients with diabetes: a retrospective review. Diabet Foot Ankle[Published online ahead of print February 20,2012; doi:10.3402/dfa.v3i0.10204].22403742)| false
Younes N, Albsoul A, Badran D, et al: Wound bed preparation with 10-percent phenytoin ointment increases the take of split-thickness skin graft in large diabetic ulcers. Dermatol Online J12: 5, 2006.10.5070/D398T188X017083885)| false
Aerden D, Bosmans I, Vanmierlo B, et al: Skin grafting the contaminated wound bed: reassessing the role of the preoperative swab. J Wound Care22: 85, 2013.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000314589200011&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f32366566310.12968/jowc.2013.22.2.85)| true
Schneider AM, Morykwas MJ, Argenta LC: A new and reliable method of securing skin grafts to the difficult recipient bed. Plast Reconstr Surg102: 1195, 1998.10.1097/00006534-199809020-000459734445)| false
Akhtar S, Ahmad I, Khan AH, et al: Modalities of soft-tissue coverage in diabetic foot ulcers. Adv Skin Wound Care28: 157, 2015.25775199http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000351672000004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f310.1097/01.ASW.0000460889.44609.0c)| true
There is an increased prevalence of foot ulceration in patients with diabetes, leading to hospitalization. Early wound closure is necessary to prevent further infections and, ultimately, lower-limb amputations. There is no current evidence stating that an elevated preoperative hemoglobin A1c (HbA1c) level is a contraindication to skin grafting. The purpose of this review was to determine whether elevated HbA1c levels are a contraindication to the application of skin grafts in diabetic patients.
A retrospective review was performed of 53 consecutive patients who underwent split-thickness skin graft application to the lower extremity between January 1, 2012, and December 31, 2015. A uniform surgical technique was used across all of the patients. A comparison of HbA1c levels between failed and healed skin grafts was reviewed.
Of 43 surgical sites (41 patients) that met the inclusion criteria, 27 healed with greater than 90% graft take and 16 had a skin graft that failed. There was no statistically significant difference in HbA1c levels in the group that healed a skin graft compared with the group in which skin graft failed to adhere.
Preliminary data suggest that an elevated HbA1c level is not a contraindication to application of a skin graft. The benefits of early wound closure outweigh the risks of skin graft application in patients with diabetes.
Corresponding author: Lawrence A. Lavery, DPM, Department of Plastic Surgery, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390. (E-mail: firstname.lastname@example.org)